| Literature DB >> 14738553 |
V Soriano1, J M Miró, J García-Samaniego, J Torre-Cisneros, M Núñez, J del Romero, L Martín-Carbonero, J Castilla, J A Iribarren, C Quereda, M Santín, J González, J R Arribas, I Santos, J Hernández-Quero, E Ortega, V Asensi, M A del Pozo, J Berenguer, C Tural, B Clotet, M Leal, J Mallolas, J M Sánchez-Tapias, S Moreno, J M Gatell, M J Téllez, R Rubio, E Ledesma, P Domingo, P Barreiro, J Pedreira, M Romero, J González-Lahoz, E Lissen.
Abstract
Chronic hepatitis B and C represent a leading cause of morbidity and mortality among human immunodeficiency virus (HIV)-infected patients worldwide. New treatment options against both hepatitis B (HBV) and C (HCV) viruses have prompted us to update previous recommendations for the management of coinfected individuals. Fifteen topics (nine related to HCV, five to HBV and one to both viruses) were selected for this purpose. A panel of Spanish experts in the field was invited to review these areas and propose specific recommendations, which were scored according to the Infectious Disease Society of America (IDSA) grading system. These guidelines represent a comprehensive and updated overview on the management of hepatitis B and C in HIV-infected patients.Entities:
Mesh：
Substances：
Year: 2004 PMID： 14738553 DOI： 10.1046/j.1365-2893.2003.00491.x
Source DB: PubMed Journal: J Viral Hepat ISSN： 1352-0504 Impact factor: 3.728